| NK cells and solid tumors: therapeutic potential and persisting obstacles L Tong, C Jiménez-Cortegana, AHM Tay, S Wickström, L Galluzzi, ... Molecular cancer 21 (1), 206, 2022 | 61 | 2022 |
| Restoration of dystrophin expression in mice by suppressing a nonsense mutation through the incorporation of unnatural amino acids N Shi, Q Yang, H Zhang, J Lu, H Lin, X Yang, A Abulimiti, J Cheng, ... Nature Biomedical Engineering 6 (2), 195-206, 2022 | 28 | 2022 |
| A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models AHM Tay, R Prieto-Díaz, S Neo, L Tong, X Chen, V Carannante, B Önfelt, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 12 | 2022 |
| Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25+/CD54+ NK cells Z Chen, Y Yang, SY Neo, H Shi, Y Chen, AK Wagner, K Larsson, L Tong, ... EMBO reports 22 (3), e51329, 2021 | 9 | 2021 |
| Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells SY Neo, X Jing, L Tong, D Tong, J Gao, Z Chen, MC De Los Santos, ... Journal for Immunotherapy of Cancer 10 (10), 2022 | 7 | 2022 |
| Optimizing eRF1 to enable the genetic encoding of three distinct noncanonical amino acids in mammalian cells N Shi, L Tong, H Lin, Z Zheng, H Zhang, L Dong, Y Yang, Y Shen, Q Xia Advanced Biology 6 (11), 2200092, 2022 | 6 | 2022 |
| Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction X Chen, EG Sifakis, S Robertson, SY Neo, SH Jun, L Tong, AT Hui Min, ... Proceedings of the National Academy of Sciences 120 (1), e2209856120, 2023 | 5 | 2023 |
| A new process for the total synthesis of Sparstolonin B X Tang, L Tong, M Yao, Q Liang, X Wang, H Yu Synlett 28 (10), 1187-1190, 2017 | 5 | 2017 |
| CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression Z Chen, L Tong, SY Neo, S Li, J Gao, S Schlisio, A Lundqvist Oncoimmunology 12 (1), 2175517, 2023 | 2 | 2023 |
| Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment W Cui, A Subramani, P Fonseca, Y Zhang, L Tong, Y Zhang, L Egevad, ... Cells 12 (17), 2158, 2023 | 2 | 2023 |
| Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease SY Neo, MMS Oliveira, L Tong, Y Chen, Z Chen, S Cismas, N Burduli, ... Journal of Experimental & Clinical Cancer Research 43 (1), 13, 2024 | 1 | 2024 |
| Generation of mega brown adipose tissue in adults by controlling brown adipocyte differentiation in vivo Q Du, J Wu, C Fischer, T Seki, X Jing, J Gao, X He, K Hosaka, L Tong, ... Proceedings of the National Academy of Sciences 119 (40), e2203307119, 2022 | 1 | 2022 |
| Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis SY Neo, L Tong, J Chong, Y Liu, X Jing, MMS Oliveira, Y Chen, Z Chen, ... Science Translational Medicine 16 (747), eadi2952, 2024 | | 2024 |
| A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells P Fonseca, W Cui, N Struyf, L Tong, A Chaurasiya, F Casagrande, H Zhao, ... Journal of Experimental & Clinical Cancer Research 43 (1), 107, 2024 | | 2024 |
| Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1 L Tong, V Kremer, SY Neo, Y Liu, Y Chen, AK Wagner, Y Yang, Z Chen, ... Cancer Communications 43 (7), 855, 2023 | | 2023 |
| 1668P Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction X Chen, EG Sifakis, S Robertson, SY Neo, SH Jun, L Tong, J Lövrot, ... Annals of Oncology 33, S1306, 2022 | | 2022 |
| Expanding the Genetic Code for Suppression of Premature Termination Codons to Alleviate Human Nonsense Mutation Diseases Q Yang, N Shi, H Zhang, A Abulimiti, J Cheng, H Lin, X Yang, Y Wang, ... 第十一届全国化学生物学学术会议论文摘要 (第三卷), 2019 | | 2019 |
